Cargando…

A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study

BACKGROUND: Combination therapy with prednisone or etanercept may induce earlier and/or more improvement in disease activity in Disease Modifying Anti Rheumatic Drug (DMARD) naïve non-systemic Juvenile Idiopathic Arthritis (JIA) patients. Here we present three months clinical outcome of initial trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hissink Muller, P. C. E., Brinkman, D. M. C., Schonenberg, D., Koopman-Keemink, Y., Brederije, I. C. J., Bekkering, W. P., Kuijpers, T. W., van Rossum, M. A. J., van Suijlekom-Smit, L. W. A., van den Berg, J. M., Allaart, C. F., ten Cate, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294738/ https://www.ncbi.nlm.nih.gov/pubmed/28166785 http://dx.doi.org/10.1186/s12969-017-0138-4

Ejemplares similares

Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)
por: Muller, PCE Hissink, et al.
Publicado: (2011)

No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis
por: Hissink Muller, P. C. E., et al.
Publicado: (2019)

Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target: results over 24 months of follow up
por: Spekking, Katinka, et al.
Publicado: (2023)

Patterns of clinical joint inflammation in juvenile idiopathic arthritis
por: Heckert, Sascha L, et al.
Publicado: (2023)

PReS-FINAL-2160: Intestinal microbiome in polyarticular juvenile idiopathic arthritis: a pilot study
por: Hissink Muller, PC, et al.
Publicado: (2013)

Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?
por: Hissink Muller, Petra C. E., et al.
Publicado: (2018)

Development of a web-based register for the Dutch national study on biologicals in juvenile idiopathic arthritis: http://www.abc-register.nl
por: Prince, FHM, et al.
Publicado: (2008)

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
por: Prince, FHM, et al.
Publicado: (2008)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register
por: Otten, MH, et al.
Publicado: (2013)

Long term functional outcome and quality of life of patients with refractory juvenile idiopathic arthritis treated with etanercept: results of the dutch arthritis and biologicals in children register
por: Anink, Janneke, et al.
Publicado: (2014)

A comparison of the measurement properties of the Juvenile Arthritis Functional Assessment Scale with the childhood health assessment questionnaire in daily practice
por: Bekkering, W. Peter, et al.
Publicado: (2007)

PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis
por: Anink, J, et al.
Publicado: (2013)

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis
por: Albers, HM, et al.
Publicado: (2008)

Contrast-enhanced MRI features in the early diagnosis of Juvenile Idiopathic Arthritis
por: Hemke, Robert, et al.
Publicado: (2015)

MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis
por: Barendregt, Anouk M, et al.
Publicado: (2020)

Bone health assessment of patients with juvenile idiopathic arthritis: a comparison between DXA and bonexpert
por: Nusman, Charlotte M, et al.
Publicado: (2014)

Dynamic contrast-enhanced magnetic resonance imaging of the wrist in children with juvenile idiopathic arthritis
por: Nusman, Charlotte M., et al.
Publicado: (2016)

Joint inflammation assessed by physical examination and MRI of the knee in juvenile idiopathic arthritis: low predictive value for synovitis
por: Nusman, Charlotte M, et al.
Publicado: (2014)

Contrast-enhanced MRI of the knee in children unaffected by clinical arthritis compared to clinically active juvenile idiopathic arthritis patients
por: Nusman, Charlotte M., et al.
Publicado: (2015)

Automated determination of bone age and bone mineral density in patients with juvenile idiopathic arthritis: a feasibility study
por: Anink, Janneke, et al.
Publicado: (2014)

PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis
por: Reinards, TH, et al.
Publicado: (2013)

PReS-FINAL-2052: Costs of biologics in juvenile idiopathic arthritis: past, present and future
por: Prince, FH, et al.
Publicado: (2013)

Patient-reported joint count in juvenile idiopathic arthritis: the reliability of a mannequin format
por: Anink, Janneke, et al.
Publicado: (2014)

The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis
por: Albers, HM, et al.
Publicado: (2008)

Increasing feasibility and patient comfort of MRI in children with juvenile idiopathic arthritis
por: Hemke, Robert, et al.
Publicado: (2012)

MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis
por: Anink, Janneke, et al.
Publicado: (2015)

Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls
por: Schonenberg-Meinema, Dieneke, et al.
Publicado: (2021)

Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)
por: Nassar-Sheikh Rashid, A., et al.
Publicado: (2021)

MRI evaluation of clinical remission in juvenile idiopathic arthritis
por: van Veenendaal, M, et al.
Publicado: (2011)

Illness script development in pre-clinical education through case-based clinical reasoning training
por: Keemink, Yvette, et al.
Publicado: (2018)

Juvenile idiopathic arthritis: magnetic resonance imaging of the clinically unaffected knee
por: van Gulik, E. Charlotte, et al.
Publicado: (2018)

2-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients?
por: Anink, Janneke, et al.
Publicado: (2011)

Psychometric Properties of the Pediatric Patient‐Reported Outcomes Measurement Information System Item Banks in a Dutch Clinical Sample of Children With Juvenile Idiopathic Arthritis
por: Luijten, Michiel A. J., et al.
Publicado: (2020)

Association of the CD226 (DNAM-1) Gly307Ser polymorphism with juvenile idiopathic arthritis
por: Reinards, THCM, et al.
Publicado: (2011)

Association of the CCR5Δ32 variant with juvenile idiopathic arthritis in a meta-analysis
por: Reinards, THCM, et al.
Publicado: (2011)

Impact of orientation specific surround modulation and tuning curve shape on population coding and tilt illusion in V1
por: Keemink, Sander W, et al.
Publicado: (2013)

Experiences, perspectives and expectations of adolescents with juvenile idiopathic arthritis regarding future work participation; a qualitative study
por: van Gulik, E. Charlotte, et al.
Publicado: (2020)

Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents
por: Barendregt, Anouk M., et al.
Publicado: (2017)

FISSA: A neuropil decontamination toolbox for calcium imaging signals
por: Keemink, Sander W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_db64c82j4cp6qe1ul2ldlutdni